Admission levels of high-density lipoprotein and apolipoprotein A-1 are associated with the neurologic outcome in patients with out-of-hospital cardiac arrest.
- Author:
Yong Soo SON
1
;
Kyung Su KIM
;
Gil Joon SUH
;
Woon Yong KWON
;
Min Ji PARK
;
Jung In KO
;
Taegyun KIM
Author Information
- Publication Type:Original Article
- Keywords: Heart arrest; Cholesterol, HDL; Apolipoprotein A-1; Prognosis
- MeSH: Adult; Apolipoprotein A-I*; Apolipoproteins*; Cholesterol, HDL; Heart Arrest; Humans; Intensive Care Units; Lipoproteins*; Logistic Models; Observational Study; Out-of-Hospital Cardiac Arrest*; Prognosis; Retrospective Studies; Sepsis; Survivors; Tertiary Care Centers
- From: Clinical and Experimental Emergency Medicine 2017;4(4):232-237
- CountryRepublic of Korea
- Language:English
- Abstract: OBJECTIVE: To investigate whether serum levels of high-density lipoprotein (HDL) and apolipoprotein A-1 (ApoA1), after the return of spontaneous circulation, can predict the neurologic outcome in patients with out-of-hospital cardiac arrest (OHCA). METHODS: This was a retrospective observational study conducted in a single tertiary hospital intensive care unit. All adult OHCA survivors with admission lipid profiles were enrolled from March 2013 to December 2015. Good neurologic outcome was defined as discharge cerebral performance categories 1 and 2. RESULTS: Among 59 patients enrolled, 13 (22.0%) had a good neurologic outcome. Serum levels of HDL (56.7 vs. 40 mg/dL) and ApoA1 (117 vs. 91.6 mg/dL) were significantly higher in patients with a good outcome. Areas under the HDL and ApoA1 receiver operating curves to predict good outcomes were 0.799 and 0.759, respectively. The proportion of good outcome was significantly higher in patients in higher tertiles of HDL and ApoA1 (test for trend, both P=0.003). HDL (P=0.018) was an independent predictor in the multivariate logistic regression model. CONCLUSION: Admission levels of HDL and ApoA1 are associated with neurologic outcome in patients with OHCA. Prognostic and potential therapeutic values of HDL and ApoA1 merit further evaluation in the post-cardiac arrest state, as in other systemic inflammatory conditions such as sepsis.
